Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The globin gene disorders including the thalassemias are among the most common human genetic diseases with more than 300,000 severely affected individuals born throughout the world every year. Because of the easy accessibility of purified, highly specialized, mature erythroid cells from peripheral blood, the hemoglobinopathies were among the first tractable human molecular diseases. From the 1970s onward, the analysis of the large repertoire of mutations underlying these conditions has elucidated many of the principles by which mutations occur and cause human genetic diseases. This work will summarize our current knowledge of the α-thalassemias, illustrating how detailed analysis of this group of diseases has contributed to our understanding of the general molecular mechanisms underlying many orphan and common diseases.

Original publication

DOI

10.1101/cshperspect.a011718

Type

Journal article

Journal

Cold Spring Harb Perspect Med

Publication Date

01/01/2013

Volume

3

Keywords

Global Health, Hemoglobinopathies, Humans, Incidence, Mutation, Phenotype, RNA, Antisense, Rare Diseases, Translocation, Genetic, Up-Regulation, alpha-Globins, alpha-Thalassemia